CUTANEOUS LUPUS ERYTHEMATOSUS
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could ease lupus skin rashes in major trial
Disease control Recruiting nowThis study tests a drug called enpatoran for people with lupus who have active skin rashes or lesions. About 202 participants will take either enpatoran or a placebo twice daily for 24 weeks, alongside their usual treatments. The goal is to see if the drug can significantly impro…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Scientists probe hidden clot risks in autoimmune skin disorders
Knowledge-focused Recruiting nowThis study looks at blood clotting in people with autoimmune skin diseases like bullous pemphigoid and lupus. Researchers will collect blood samples from 39 participants—some with active disease and some with mild or controlled disease—plus 15 healthy controls. They will measure …
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
1,000 lupus patients join hunt for skin disease genes
Knowledge-focused Recruiting nowThis study aims to collect genetic and protein data from 1,000 people with lupus-related skin disease. Researchers hope to identify the genes and proteins that cause skin lesions in lupus. The goal is to better understand the disease, improve diagnosis, and spark new drug develop…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC